Purdue Pharma and the Anti-Kickback Statute in the Opioid Crisis
This paper examines Purdue Pharma's role in the opioid crisis through the lens of the federal Anti-Kickback Statute, which prohibits companies from providing payments to healthcare providers in exchange for prescribing federally reimbursable drugs or services. The paper discusses the statute's history and purpose, details Purdue Pharma's alleged kickback practices used to promote OxyContin, and explores the broader cultural failures within the pharmaceutical and healthcare industries that enabled such misconduct. It also offers guidance on how hospitals and organizational leadership can cultivate ethical cultures, prioritize preventive care, and implement safeguards to avoid similar violations in the future.
- Introduction: Overview of Anti-Kickback Statute and Purdue Pharma case
- The Anti-Kickback Statute's Importance: Statute's purpose, history, and role in healthcare
- Purdue Pharma's Role in the Opioid Epidemic: Purdue's OxyContin marketing and kickback allegations
- What a Hospital Could Do to Protect Itself: Organizational culture and compliance strategies for hospitals
- How Organizational Leadership Could Move Forward: Leadership reforms to prevent future statutory violations
- Conclusion: Synthesis of legal, cultural, and preventive care themes
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- It grounds the analysis in a specific federal statute, giving the argument a clear legal framework rather than relying on vague ethical claims.
- The paper moves logically from law to case study to practical recommendation, giving it a coherent applied-ethics structure.
- It connects macro-level industry culture (treatment vs. prevention) to organizational-level consequences, adding analytical depth beyond the courtroom facts.
Key academic technique demonstrated
The paper uses a real legal case as a lens to apply statutory analysis and organizational ethics simultaneously. By anchoring each section in the Anti-Kickback Statute and then expanding outward to cultural and leadership implications, the writer demonstrates the ability to move between legal specificity and broader healthcare policy argument — a technique common in health law and public health writing.
Structure breakdown
The paper opens with a historical and legal overview of the Anti-Kickback Statute, then narrows to Purdue Pharma's specific conduct. The middle sections shift perspective — first to what a hospital can do defensively, then to what leadership reform might look like. The conclusion synthesizes all threads by returning to the statute's original purpose and the need for a cultural shift toward preventive care. This funnel-and-widen structure is well suited to applied ethics and healthcare policy topics.
Introduction
The court case of US v. Purdue Pharma focuses on the Anti-Kickback Statute, which holds it a felony for an entity to accept kickbacks for providing services or items that are reimbursable by a federal program (Baird, 2021). Part of the problem with this case and others like it is that not everyone agrees on what constitutes a kickback. For example, Illiparambil (2020) writes in the Brooklyn Law Review that pharmaceutical "donations" should not be viewed as kickbacks — even though prosecutors could and have made the case that they function as such. Kickback laws have been in existence for decades, however, with the first going all the way back to 1931 (Raspanti, Roberts & Bosick, 2017).
Today, the Anti-Kickback Statute has led to prosecutions and settlements with pharmaceutical companies like Purdue Pharma for over half a billion dollars (Kraschel & Curfman, 2019). The statute is a costly one to violate, with offenders liable for $100,000 per violation if convicted (Gore, 2020). Part of the problem is that the culture of health care today focuses so heavily on treatments that industries like the pharmaceutical industry thrive because they know there is a market for their drugs. It therefore becomes a matter of getting their drugs into the hands of health care providers who then prescribe them to patients — and to accomplish that requires some form of incentive, such as a rebate or donation.
Create your account
Always verify citation format against your institution’s current style guide requirements.